CMS-Deemed Accreditation
DMEPOS Certification

Board of Certification/Accreditation

CMS-Deemed Accreditation
DMEPOS Certification

Our Board of Directors

Cameron Stewart, BOCO, BOCP

BOC Board Chair

“I am deeply honored to serve as Chairman of the BOC Board of Directors. This organization plays a vital role in advancing the standards and recognition of excellence in orthotics, prosthetics and durable medical equipment. I look forward to continuing our mission and ensuring BOC credentials remain a symbol of quality, competence and commitment to patient care.”

2025 Executive Committee

Name Position
Cameron Stewart, BOCO, BOCP Chair
Abel Guevara III, DHA, MHIM, FACHDM, RHIA, mMBA, CPhT-Adv, CDME Vice-Chair
Angela Presley, Ph.D., BOCPD, COF Secretary
Daniel Griffis III, PharmD Treasurer
Bradley “Brad” Watson, BOCO, BOCP, LPO Member-at-Large
Wayne R. Rosen, BOCP, BOCO, LPO, CDME, FAAOP Immediate Past Chair (Retired)
Judi L. Knott, MA, MBA President & CEO

 

2025 Directors

 

Name Position
Sangeeta Bhambhani, BOCO, BOCP Member
Bill Chaudhry, CDME Member
Farrell Friedenberg, CMF Member
Von M. Homer, PhD, M.Sc., BOCPD Member
Diana Klunk, CMF Member
James Mathers, COF Member
Jason Morin, MBA, RRT, CDME Public Member
Michael Silverman, Esq., CDME Member
Richard Todd, COF Member

December 18, 2025

Statement from Board of Certification/Accreditation (BOC) Regarding Facility Accreditation

Note: All BOC certification programs remain relevant and valid for the thousands of providers holding BOC credentials.

The Board of Certification/Accreditation (BOC) confirms that the Centers for Medicare and Medicaid Services (CMS) notified BOC of its decision to immediately withdraw BOC’s status as a ‘deemed’ accrediting organization (AO) effective December 2, 2025.

BOC has sought guidance from CMS on how CMS plans to operationalize this abrupt change for BOC's customers. CMS advised that all inquiries regarding impact on supplier Medicare enrollment should be directed to the following email inbox: dmeaccreditation@cms.hhs.gov.

Those who value accreditation and are committed to DMEPOS product access and patient safety understand that accreditation operations cannot be abruptly halted without resulting in a negative impact on DMEPOS suppliers and the patients/beneficiaries they serve.

In response to CMS' abrupt termination, BOC has filed Board of Certification/Accreditation International, Inc. v. Robert F. Kennedy, Jr. et al, Case No. 1:25-cv-04150-MJM, in the United States District Court of Maryland.

Since December 2, our focus has been on the DMEPOS customers most immediately impacted: new and reaccrediting facilities in the midst of completing the final requirements to confirm compliance and receive accreditation. Some of these customers were surveyed weeks prior to CMS issuing the December 2 notice of withdrawal.

BOC is dismayed by the actions of CMS, particularly with its refusal to have verbal conversations with BOC before withdrawing BOC's deemed status.

Download this statement